Fractyl Health, Inc. Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net
Fractyl Health, Inc. (GUTS) reported Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net of $210.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet · last filed 2026-08-10
- Fractyl Health, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-06-30 was -$274.00K, a 2057.14% decline year-over-year.
- Fractyl Health, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-03-31 was $484.00K, a 1628.57% increase year-over-year.
- Fractyl Health, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-12-31 was $80.00K.
- Fractyl Health, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-09-30 was $64.00K, a 42.22% increase year-over-year.
- Fractyl Health, Inc. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2025 was $186.00K.
- Fractyl Health, Inc. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2024 was -$2.33M.
- Fractyl Health, Inc. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2023 was -$74.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $210.00K 10-Q · filed 2026-08-10 | $290.00K derived: sum of 3 quarters · filed 2026-08-10 | $354.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $484.00K 10-Q · filed 2026-05-12 | $564.00K derived: sum of 2 quarters · filed 2026-05-12 | $628.00K derived: sum of 3 quarters · filed 2026-05-12 | $642.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $144.00K derived: sum of 2 quarters · filed 2026-03-24 | $158.00K derived: sum of 3 quarters · filed 2026-08-10 | $186.00K 10-K · filed 2026-03-24 |
| 2025-09-30 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $78.00K derived: sum of 2 quarters · filed 2026-08-10 | $106.00K 10-Q · filed 2025-11-12 | -$2.34M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $42.00K 10-Q · filed 2026-08-10 | -$2.40M derived: sum of 3 quarters · filed 2026-08-10 | -$2.36M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $28.00K 10-Q · filed 2026-05-12 | -$2.42M derived: sum of 2 quarters · filed 2026-05-12 | -$2.37M derived: sum of 3 quarters · filed 2026-05-12 | -$2.23M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$2.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$2.40M derived: sum of 2 quarters · filed 2026-03-24 | -$2.26M derived: sum of 3 quarters · filed 2026-03-24 | -$2.33M 10-K · filed 2026-03-24 |
| 2024-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $184.00K derived: sum of 2 quarters · filed 2025-11-12 | $117.00K 10-Q · filed 2025-11-12 | $46.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $72.00K 10-Q · filed 2025-08-12 | $1.00K derived: sum of 3 quarters · filed 2025-08-12 | -$69.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$67.00K 10-Q · filed 2025-05-13 | -$138.00K derived: sum of 2 quarters · filed 2025-05-13 | -$208.00K derived: sum of 3 quarters · filed 2025-05-13 | -$328.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$141.00K derived: sum of 2 quarters · filed 2025-03-03 | -$261.00K derived: sum of 3 quarters · filed 2025-03-03 | -$74.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$190.00K derived: sum of 2 quarters · filed 2024-11-12 | -$3.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $67.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $187.00K 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |